stockrowPTC Therapeutics, Inc.
PTCT Healthcare Biotechnology
PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.
- Revenue
- +69.6%
- EPS
- −409.7%
- Free cash flow
- +90.3%
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
Follow PTCT
Alert me
PTC Therapeutics, Inc. (PTCT) Operating cash flow
PTC Therapeutics, Inc.'s operating cash flow for fiscal 2025 was $711.2M, compared with −$107.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $10.5M. Over the past ten years it has ranged from −$356.7M (fiscal 2022) to $711.2M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. PTC Therapeutics, Inc. ranks 48th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $711.2M | — |
| FY2024 | −$107.7M | — |
| FY2023 | −$158.4M | — |
| FY2022 | −$356.7M | — |
| FY2021 | −$251.3M | — |
| FY2020 | −$194.1M | — |
| FY2019 | −$98.6M | — |
| FY2018 | −$27.6M | — |
| FY2017 | −$10.1M | — |
| FY2016 | −$103.6M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | −$25.3M | — |
| Jun 2026 | $129.1M | — |
| Mar 2026 | −$59.0M | — |
| Dec 2025 | −$34.3M | — |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| PTCT PTC Therapeutics, Inc. | $10.5M |
| BLTE Belite Bio, Inc. Sponsored ADR compare | −$66.2M |
| MANE Veradermics Incorporated compare | −$122.9M |
| KOD Kodiak Sciences Inc. compare | −$158.5M |
| CGON CG Oncology, Inc. compare | −$178.5M |
| MIRM Mirum Pharmaceuticals, Inc. compare | −$271.3M |
| SRRK Scholar Rock Holding Corporation compare | −$296.8M |
| COGT Cogent Biosciences, Inc. compare | −$307.5M |
| IMVT Immunovant, Inc. compare | −$414.3M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on PTCT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement